Can Third-Party Auditors Conduct Drug Quality Audits In Japan?

Yes, third-party auditors can conduct drug quality audits in Japan. The Pharmaceuticals and Medical Devices Agency (PMDA) allows third-party audits to ensure compliance with Good Manufacturing Practices (GMP). These auditors must be accredited and follow PMDA guidelines to assess manufacturing processes, ensuring drug safety and efficacy in the Japanese market.

Leave a Reply

You must be logged in to post a comment.